A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
To evaluate the safety and efficacy of foscarnet induction therapy for treatment of AIDS patients experiencing their first episode of cytomegalovirus (CMV) retinitis. To evaluate the safety and efficacy of foscarnet maintenance therapy for treatment of AIDS patients experiencing CMV retinitis.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||An Open Study of Foscarnet Treatment of CMV-Retinitis in AIDS Patients|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002432
|United States, California|
|Davies Med Ctr|
|San Francisco, California, United States, 94114|